Although further BACE1 selectivity over cathepsins D and BACE2 and in vivo studies are required to confirm our findings, these PMFs showed significant and selective inhibitory activities against BACE1, and can be used as potential agents for preventing and/or treating AD. This evidence concerns the gene CTSD and Alzheimer disease.